lamotrigine has been researched along with lacosamide in 40 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 21 (52.50) | 24.3611 |
| 2020's | 19 (47.50) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Béguin, C; Carlezon, WA; Cohen, BM; Potter, DN; Stöhr, T | 1 |
| Helmstaedter, C; Witt, JA | 1 |
| Alpdogan, S; Dibué, M; Hescheler, J; Kamp, MA; Neiss, WF; Schneider, T; Tevoufouet, EE | 1 |
| Jin, DI; Kang, JW; Lee, JE; Lee, SH; Lin, T | 1 |
| Rheims, S; Ryvlin, P | 1 |
| Kumar, D; Laurenza, A; Meador, KJ; Piña-Garza, JE; Wesnes, KA; Yang, H | 1 |
| Bastin, ML; Cook, AM; Oyler, DR; Smetana, KS | 1 |
| Andres-Mach, M; Florek-Łuszczki, M; Patrzylas, P; Pyrka, D; Skalicka-Woźniak, K; Szpringer, M; Zagaja, M; Żółkowska, D; Łuszczki, JJ | 1 |
| de Paoli, FV; Nielsen, OB; Pedersen, TH; Skov, M | 1 |
| Chan, EL; Chan, I; Chang, RS; Fong, GC; Fong, JK; Fung, BB; Fung, EL; Leung, H; Lui, CH; Poon, TL; Siu, D; Wong, HT; Yeung, E; Yung, AW; Zhu, CX | 1 |
| Tikhonov, DB; Zhorov, BS | 1 |
| Daniluk, J; Drop, B; Sawicka, KM; Szczyrek, M; Szpringer, M; Wawryniuk, A; Załuska, K; Załuska-Patel, K; Żółkowska, D; Łuszczki, JJ | 1 |
| Coppola, G; Operto, FF; Piccorossi, A; Verrotti, A | 1 |
| Alpdogan, S; Dibué-Adjei, M; Hescheler, J; Kamp, MA; Neiss, WF; Schneider, T; Tevoufouet, EE | 1 |
| Kondrat-Wróbel, MW; Łuszczki, JJ | 1 |
| Gálvez, A; Hancock, CL | 1 |
| Chmielewski, J; Daniluk, J; Florek-Łuszczki, M; Karwan, S; Sawicka, KM; Wawryniuk, A; Wróblewska-Łuczka, P; Łuszczki, JJ | 1 |
| Nieoczym, D; Socała, K; Szafarz, M; Wlaź, P; Wyska, E | 1 |
| Brigo, F; Lattanzi, S; Verrotti, A; Zaccara, G | 1 |
| Kaimovsky, IL; Mkrtchyan, VR | 1 |
| Goji, A; Kagami, S; Mori, T; Tayama, T; Toda, Y | 1 |
| Bojar, H; Florek-Łuszczki, M; Karwan, S; Kondrat-Wróbel, M; Plewa, Z; Zagaja, M; Łuszczki, JJ | 1 |
| Hayashi, T; Noguchi, Y; Tachi, T; Takaoka, M; Teramachi, H | 1 |
| Feng, J; Li, HJ; Ma, L; Sun, L; Sun, Y; Wang, TT; Yu, J; Yu, LH; Zhao, T | 1 |
| Chang, YP; Huang, LC; Li, KY; Yang, YH | 1 |
| Adamovich-Zeitlin, RH; Camp, EJ; Gross, RE; Jobst, BC; Kahana, MJ; Lega, BC; MacKenzie, TA; Meisenhelter, S; Quon, RJ; Song, Y; Sperling, MR; Steimel, SA; Testorf, ME | 1 |
| Bialer, M; Franco, V; Odi, R; Perucca, E | 1 |
| Bien, CG; Brandt, C; Dufaux, B; Hagemann, A; Klimpel, D; May, TW | 1 |
| Bojar, H; Florek-Łuszczki, M; Marzęda, P; Plewa, Z; Wróblewska-Łuczka, P; Załuska-Ogryzek, K; Zolkowska, D; Łuszczki, JJ | 1 |
| Bromley, RL; Knight, R; Wittkowski, A | 1 |
| Dirven, L; Fiocco, M; Koekkoek, JAF; Kouwenhoven, MCM; Taphoorn, MJB; van den Bent, MJ; van der Meer, PB; van Opijnen, MP | 1 |
| Bhatt, D; Golamari, R; Groff, A; Jain, R; Kalayanamitra, R; Maddukari, A; Packard, E; Patel, R; Polimera, H; Roy, J; Sahu, N; Shahid, Z; Vunnam, R | 1 |
| Birnbaum, AK; Gerard, E; Kalayjian, L; Karanam, A; Matthews, A; McElrath, TM; Meador, KJ; Pennell, PB; Penovich, P | 1 |
| Burke, JF; Choi, H; Terman, SW; Youngerman, BE | 1 |
| Groppa, S; Klimpe, S; Sandner, K; Stuckrad-Barre, SV; Uphaus, T; Winter, Y | 1 |
| Battino, D; Bromley, R; Kochen, S; Meador, KJ; Pennell, PB; Thomas, SV; Tomson, T | 1 |
| Schubert-Bast, S; Strzelczyk, A | 1 |
| Bien, CG; Brandt, C; Dufaux, B; Hagemann, A; Klimpel, D; May, TW; Schmitter, E | 1 |
11 review(s) available for lamotrigine and lacosamide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pharmacotherapy for tonic-clonic seizures.
Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Risk Factors; Seizures; Topiramate; Treatment Failure; Triazines; Valproic Acid | 2014 |
Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy.
Topics: Acetamides; Acute Kidney Injury; Amines; Anticonvulsants; Carbamates; Critical Illness; Cyclohexanecarboxylic Acids; Dibenzazepines; Dose-Response Relationship, Drug; Ethosuximide; Felbamate; Fructose; Gabapentin; gamma-Aminobutyric Acid; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Phenobarbital; Phenylcarbamates; Phenylenediamines; Phenytoin; Piracetam; Propylene Glycols; Renal Dialysis; Renal Replacement Therapy; Seizures; Topiramate; Triazines; Valproic Acid; Zonisamide | 2016 |
An update of the Hong Kong Epilepsy Guideline: consensus statement on the use of antiepileptic drugs in Hong Kong.
Topics: Acetamides; Anticonvulsants; Carbamazepine; Consensus; Drugs, Generic; Epilepsy; Hong Kong; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Piracetam; Practice Guidelines as Topic; Societies, Medical; Triazines | 2017 |
Anticonvulsant drugs for generalized tonic-clonic epilepsy.
Topics: Acetamides; Anticonvulsants; Epilepsy, Generalized; Epilepsy, Tonic-Clonic; Female; Fructose; Humans; Isoxazoles; Lacosamide; Lamotrigine; Levetiracetam; Male; Nitriles; Piracetam; Pyridones; Randomized Controlled Trials as Topic; Topiramate; Treatment Outcome; Triazines; Valproic Acid; Zonisamide | 2017 |
Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice.
Topics: Animals; Anticonvulsants; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Epilepsy; Humans; Lacosamide; Lamotrigine; Prospective Studies; Valproic Acid | 2020 |
The effects of lacosamide on cognitive function and psychiatric profiles in patients with epilepsy.
Topics: Adult; Affect; Anticonvulsants; Carbamazepine; Cognition; Epilepsy; Humans; Lacosamide; Lamotrigine; Nitriles; Pyridones; Quality of Life; Topiramate | 2020 |
Bioequivalence and switchability of generic antiseizure medications (ASMs): A re-appraisal based on analysis of generic ASM products approved in Europe.
Topics: Anticonvulsants; Area Under Curve; Biological Variation, Individual; Dibenzazepines; Drug Substitution; Drugs, Generic; Europe; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregabalin; Therapeutic Equivalency; Topiramate; Vigabatrin; Zonisamide | 2021 |
Neurodevelopmental outcomes in children exposed to newer antiseizure medications: A systematic review.
Topics: Anticonvulsants; Child; Female; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregnancy; Topiramate; Zonisamide | 2021 |
Breastfeeding while on treatment with antiseizure medications: a systematic review from the ILAE Women Task Force
Topics: Breast Feeding; Cannabidiol; Carbamazepine; Child; Clobazam; Clonazepam; Epilepsy; Ethosuximide; Everolimus; Felbamate; Female; Fenfluramine; Gabapentin; Humans; Infant; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Phenobarbital; Phenytoin; Prospective Studies; Tiagabine; Topiramate; Valproic Acid; Vigabatrin; Zonisamide | 2022 |
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Topics: Autism Spectrum Disorder; Bromides; Cannabidiol; Clobazam; Cognition; Ethosuximide; Everolimus; Felbamate; Fenfluramine; Humans; Lacosamide; Lamotrigine; Levetiracetam; Pregabalin; Spasms, Infantile; Sulfides; Topiramate; Valproic Acid; Vigabatrin; Zinc Compounds; Zonisamide | 2022 |
1 trial(s) available for lamotrigine and lacosamide
| Article | Year |
|---|---|
Cognitive effects of adjunctive perampanel for partial-onset seizures: A randomized trial.
Topics: Acetamides; Adolescent; Anticonvulsants; Attention; Carbamazepine; Child; Cognition; Double-Blind Method; Drug Therapy, Combination; Epilepsies, Partial; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Memory, Short-Term; Neuropsychological Tests; Nitriles; Oxcarbazepine; Piracetam; Pyridones; Topiramate; Treatment Outcome; Triazines; Valproic Acid | 2016 |
28 other study(ies) available for lamotrigine and lacosamide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats.
Topics: Acetamides; Animals; Anticonvulsants; Cocaine; Lacosamide; Lamotrigine; Male; Rats; Rats, Sprague-Dawley; Reinforcement Schedule; Reward; Self Stimulation; Treatment Outcome; Triazines; Valproic Acid | 2012 |
The longer-term cognitive effects of adjunctive antiepileptic treatment with lacosamide in comparison with lamotrigine and topiramate in a naturalistic outpatient setting.
Topics: Acetamides; Adolescent; Adult; Anticonvulsants; Cognition; Epilepsy; Executive Function; Female; Fructose; Humans; Lacosamide; Lamotrigine; Male; Memory; Middle Aged; Neuropsychological Tests; Outpatients; Quality of Life; Retrospective Studies; Topiramate; Treatment Outcome; Triazines | 2013 |
Cav 2.3 (R-type) calcium channels are critical for mediating anticonvulsive and neuroprotective properties of lamotrigine in vivo.
Topics: Acetamides; Animals; Anticonvulsants; Calcium Channels, R-Type; Cation Transport Proteins; Disease Models, Animal; Electroencephalography; Fructose; Hippocampus; Lacosamide; Lamotrigine; Mice; Seizures; Topiramate; Triazines | 2013 |
Teratogenic potential of antiepileptic drugs in the zebrafish model.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Disease Models, Animal; Ethosuximide; Female; Fructose; Humans; Lacosamide; Lamotrigine; Levetiracetam; Piracetam; Pregnancy; Teratogenesis; Topiramate; Triazines; United States; Valproic Acid; Zebrafish | 2013 |
Influence of xanthotoxin (8-methoxypsoralen) on the anticonvulsant activity of various novel antiepileptic drugs against maximal electroshock-induced seizures in mice.
Topics: Acetamides; Animals; Anticonvulsants; Carbamazepine; Drug Synergism; Electroshock; Fructose; Lacosamide; Lamotrigine; Male; Methoxsalen; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate; Triazines | 2016 |
The anti-convulsants lacosamide, lamotrigine, and rufinamide reduce myotonia in isolated human and rat skeletal muscle.
Topics: Acetamides; Animals; Anthracenes; Anticonvulsants; Area Under Curve; Dose-Response Relationship, Drug; Drug Synergism; Electric Stimulation; Female; Humans; In Vitro Techniques; Isometric Contraction; Lacosamide; Lamotrigine; Male; Muscle, Skeletal; Myotonia; Rats; Rats, Wistar; Triazines; Triazoles | 2017 |
Mechanism of sodium channel block by local anesthetics, antiarrhythmics, and anticonvulsants.
Topics: Acetamides; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Benzhydryl Compounds; Binding Sites; Carbamazepine; Cocaine; Humans; Lacosamide; Lamotrigine; Lidocaine; Molecular Docking Simulation; NAV1.4 Voltage-Gated Sodium Channel; Phenols; Phenytoin; Piperazines; Protein Binding; Pyrimidines; Quinidine; Sodium Channel Blockers; Triazines | 2017 |
Ivabradine attenuates the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Topics: Acetamides; Animals; Anticonvulsants; Benzazepines; Brain; Cardiovascular Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Electroshock; Epilepsy, Tonic-Clonic; Fructose; Ivabradine; Lacosamide; Lamotrigine; Male; Mice; Pregabalin; Topiramate; Triazines | 2017 |
Cav2.3 (R-Type) Calcium Channels are Critical for Mediating Anticonvulsive and Neuroprotective Properties of Lamotrigine In Vivo.
Topics: Acetamides; Animals; Anticonvulsants; Behavior, Animal; Calcium Channels, R-Type; Electrocorticography; Epilepsy; Fructose; Genotype; Immunohistochemistry; Kainic Acid; Lacosamide; Lamotrigine; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuroprotective Agents; Pyramidal Cells; Topiramate; Triazines | 2017 |
Isobolographic additivity among lacosamide, lamotrigine and phenobarbital in a mouse tonic-clonic seizure model.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Epilepsy; Lacosamide; Lamotrigine; Male; Mice; Phenobarbital; Seizures | 2018 |
Lamotrigine-associated hemophagocytic lymphohistiocytosis.
Topics: Biopsy; Bone Marrow; Dexamethasone; Drug Resistant Epilepsy; Etoposide; Ferritins; Humans; Interleukin-2 Receptor alpha Subunit; Lacosamide; Lamotrigine; Leukopenia; Lymphohistiocytosis, Hemophagocytic; Male; Middle Aged; Thrombocytopenia; Transaminases | 2019 |
Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Disease Models, Animal; Dronedarone; Drug Synergism; Drug Therapy, Combination; Lacosamide; Lamotrigine; Male; Mice; Pregabalin; Seizures; Topiramate | 2019 |
Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.
Topics: Animals; Anticonvulsants; Brain; Cannabidiol; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Interactions; Drug Resistant Epilepsy; Electric Stimulation; Gabapentin; Lacosamide; Lamotrigine; Levetiracetam; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Tiagabine; Topiramate | 2019 |
[Pharmacoeconomic aspects of monotherapy of focal epilepsy].
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Cost-Benefit Analysis; Economics, Pharmaceutical; Epilepsies, Partial; Humans; Lacosamide; Lamotrigine; Oxcarbazepine; Retrospective Studies | 2019 |
Improvement of epilepsy with lacosamide in a patient with ring chromosome 20 syndrome.
Topics: Anticonvulsants; Carbamazepine; Child; Electroencephalography; Epilepsy; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Ring Chromosomes; Seizures; Treatment Outcome; Valproic Acid | 2020 |
Sub-additive (antagonistic) interaction of lacosamide with lamotrigine and valproate in the maximal electroshock-induced seizure model in mice: an isobolographic analysis.
Topics: Animals; Anticonvulsants; Dose-Response Relationship, Drug; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Lacosamide; Lamotrigine; Male; Mice; Seizures; Valproic Acid | 2020 |
Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Topics: Anticonvulsants; Carbamazepine; Clobazam; Clonazepam; Databases, Factual; Drug Therapy, Combination; Epilepsy; Gabapentin; Humans; Japan; Lacosamide; Lamotrigine; Levetiracetam; Lorazepam; Pharmacovigilance; Phenytoin; Stevens-Johnson Syndrome; Valproic Acid | 2020 |
Development and validation of an innovative UPLC method to quantify lacosamide, oxcarbazepine, and lamotrigine in the serum of children with epilepsy in China.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; China; Chromatography, High Pressure Liquid; Epilepsy; Humans; Infant; Lacosamide; Lamotrigine; Limit of Detection; Linear Models; Oxcarbazepine; Reproducibility of Results | 2021 |
Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Drug Resistant Epilepsy; Electrocorticography; Female; Humans; Lacosamide; Lamotrigine; Levetiracetam; Male; Mental Recall; Middle Aged; Phenytoin; Time Factors; Topiramate; Zonisamide | 2021 |
Therapeutic Drug Monitoring of Lamotrigine, Lacosamide, and Levetiracetam in Dried Capillary Blood-Determination of Conversion Factors for Serum-Based Reference Ranges.
Topics: Adult; Anticonvulsants; Dried Blood Spot Testing; Drug Monitoring; Humans; Lacosamide; Lamotrigine; Levetiracetam; Reference Values; Serum | 2021 |
Interactions among Lacosamide and Second-Generation Antiepileptic Drugs in the Tonic-Clonic Seizure Model in Mice.
Topics: Animals; Anticonvulsants; Disease Models, Animal; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Electroshock; Epilepsy; Lacosamide; Lamotrigine; Male; Mice; Oxcarbazepine; Pregabalin; Seizures; Topiramate | 2021 |
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
Topics: Anticonvulsants; Epilepsy; Glioma; Humans; Lacosamide; Lamotrigine; Retrospective Studies; Seizures; Treatment Outcome | 2021 |
DRESS is a Mess: A Case of Cross Reactivity Between Lacosamide and Lamotrigine.
Topics: Anticonvulsants; Eosinophilia; Humans; Lacosamide; Lamotrigine; Syndrome | 2021 |
Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Lacosamide; Lamotrigine; Levetiracetam; Oxcarbazepine; Pregnancy; Prospective Studies; Topiramate; Zonisamide | 2022 |
Antiseizure medication treatment pathways for US Medicare beneficiaries with newly treated epilepsy.
Topics: Aged; Anticonvulsants; Epilepsy; Gabapentin; Humans; Lacosamide; Lamotrigine; Levetiracetam; Medicare; Retrospective Studies; United States; Valproic Acid | 2022 |
Efficacy and safety of antiseizure medication in post-stroke epilepsy.
Topics: Anticonvulsants; Epilepsies, Partial; Epilepsy; Humans; Lacosamide; Lamotrigine; Levetiracetam; Seizures; Sodium Channels; Stroke; Valproic Acid | 2022 |
Validation of Conversion Factors for Therapeutic Drug Monitoring of Lacosamide, Lamotrigine, and Levetiracetam in Dried Capillary Blood.
Topics: Adult; Anticonvulsants; Drug Monitoring; Epilepsy; Humans; Lacosamide; Lamotrigine; Levetiracetam | 2023 |